Serum Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor–binding Protein 2 as a Novel Biomarker in the Detection of Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

Serum Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor–binding Protein 2 as a Novel Biomarker in the Detection of Pancreatic Adenocarcinoma

Published:2019-12-16 Issue:9 Volume:54 Page:e83-e88
ISSN:0192-0790
Container-title:Journal of Clinical Gastroenterology
language:en
Short-container-title:

Author:

Wlodarczyk Barbara,Borkowska Anna,Wlodarczyk Przemyslaw,Malecka-Panas Ewa,Gasiorowska Anita

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference59 articles.

1. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study;Berrino;Lancet Oncol,2007

2. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer;Pannala;Lancet Oncol,2009

3. Detecting pancreatic cancer early: problems and prospects;Chari;Semin Oncol,2007

4. Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis;Gangi;AJR Am J Roentgenol,2004

5. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis;Pelaez-Luna;Am J Gastroenterol,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increase in urine albumin-to-creatinine ratio as one of the earliest markers of renal damage in patients with hypertension and type 2 diabetes mellitus;INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine);2024-08-02

2. Prognostic and diagnostic value of circulating IGFBP2 in pancreatic cancer;Open Medicine;2024-01-01

3. Molecular testing in pancreatic cancer;Diagnostic Molecular Pathology;2024

4. Prospective of Pancreatic Cancer Diagnosis Using Cardiac Sensing;Journal of Imaging;2023-07-25

5. CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation;Journal of Clinical Medicine;2023-06-14